Narjust Florez, Co-Director of Young Lung Cancer Program at Dana-Farber Cancer Institute, shared on LinkedIn:
“A seat at the table. A voice for our patients. A responsibility to move the field forward.
Honored to serve on the IASLC Board of Directors, uniting our global community and shaping the future of lung cancer care at WCLC2026 in Seoul.
The work continues.
You know you’re getting older when your travel essentials go from cute outfits and extra shoes to Tiger Balm, a massage gun, and sleepy-time tea.
Ready for WCLC26… physically pending.
First night in Seoul: bright lights, busy streets, fried chicken, banana milk, and absolutely no idea where I was going. The adventure begins!
IASLC has played such an important role in my career.
I am especially grateful to Dr. Van Schil for his unwavering support throughout the years, from being selected as WCLC Chair, to chairing WCLC 2024, becoming a Board Member-Elect, and now serving as an IASLC Board Member.
First picture with the official WCLC26 mascots secured! Clearly, I have already met some of the most important attendees.
Your mission: find them, say hi, take a picture, and don’t forget to tag IASLC.
When the selfie wall becomes your personal video studio.
Find the perfect backdrop at WCLC26 and strike a pose!
Tomorrow at WCLC26! Join us as we move exercise in lung cancer from evidence to global implementation and launch IREX-LUNG, a new international collaborative network.
- Sept 12 | 8–10 AM
- Room 300, Conference Room South, 3F
Grateful for the view of the Bongeunsa Temple (봉은사) from my hotel room at WCLC26.
You can also read:
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
